These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29651707)

  • 1. [Radiochemotherapy for invasive bladder cancer : An update].
    Tselis N; Prott FJ; Ott O; Weiss C; Rödel C
    Urologe A; 2018 Jun; 57(6):679-685. PubMed ID: 29651707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer.
    Birkenhake S; Martus P; Kühn R; Schrott KM; Sauer R
    Strahlenther Onkol; 1998 Mar; 174(3):121-7. PubMed ID: 9524620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
    J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2).
    Merten R; Ott O; Haderlein M; Bertz S; Hartmann A; Wullich B; Keck B; Kühn R; Rödel CM; Weiss C; Gall C; Uter W; Fietkau R
    Oncologist; 2019 Dec; 24(12):e1341-e1350. PubMed ID: 31292267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.
    Housset M; Maulard C; Chretien Y; Dufour B; Delanian S; Huart J; Colardelle F; Brunel P; Baillet F
    J Clin Oncol; 1993 Nov; 11(11):2150-7. PubMed ID: 8229129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
    Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
    BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients.
    Kageyama Y; Okada Y; Arai G; Hyochi N; Suzuki M; Masuda H; Hayashi T; Kawakami S; Okuno T; Ishizaka K; Kihara K
    Jpn J Clin Oncol; 2000 Dec; 30(12):553-6. PubMed ID: 11210165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.
    Peyromaure M; Slama J; Beuzeboc P; Ponvert D; Debré B; Zerbib M
    Urology; 2004 Jan; 63(1):73-7. PubMed ID: 14751352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
    Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F
    BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.
    Sauer R; Birkenhake S; Kühn R; Wittekind C; Schrott KM; Martus P
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):121-7. PubMed ID: 9422567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infiltrating cancer of the bladder: can radiochemotherapy be an alternative to cystectomy?].
    Chrétien Y; Mejean A; Durdux C; Dufour B; Housset M
    J Urol (Paris); 1996; 102(1):3-8. PubMed ID: 8763598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
    Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.
    Tanabe K; Yoshida S; Koga F; Inoue M; Kobayashi S; Ishioka J; Tamura T; Sugawara E; Saito K; Akashi T; Fujii Y; Kihara K
    Clin Genitourin Cancer; 2015 Aug; 13(4):e243-e251. PubMed ID: 25936588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive bladder carcinoma: preliminary report of selective bladder conservation by transurethral surgery, upfront MCV (methotrexate, cisplatin, and vinblastine) chemotherapy and pelvic irradiation plus cisplatin.
    Marks LB; Kaufman SD; Prout GR; Heney NM; Griffin PP; Shipley WU
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):877-83. PubMed ID: 3182328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective bladder preservation by combination treatment of invasive bladder cancer.
    Kaufman DS; Shipley WU; Griffin PP; Heney NM; Althausen AF; Efird JT
    N Engl J Med; 1993 Nov; 329(19):1377-82. PubMed ID: 8413433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
    Akçetin Z; Todorov J; Tüzel E; Engehausen DG; Krause FS; Sauer R; Schrott KM; Rödel C
    Anticancer Res; 2005; 25(3A):1623-8. PubMed ID: 16033071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of repeat radical transurethral resection for selected patients with muscle-invasive bladder cancer.
    Li Z; Li Y; Lu Q; Chen J
    ANZ J Surg; 2018 Oct; 88(10):1033-1036. PubMed ID: 29974604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective organ preservation in muscle-invasive bladder cancer: review of the literature.
    Khosravi-Shahi P; Cabezón-Gutiérrez L
    Surg Oncol; 2012 Mar; 21(1):e17-22. PubMed ID: 22088598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.